CPT® Code 87620

Deleted

The CPT® Code 87620 refers to the detection of infectious agents through nucleic acid testing, specifically targeting the human papillomavirus (HPV) using a direct probe technique. HPV is a prevalent sexually transmitted disease that affects both men and women, with over 40 different types capable of infecting the genital areas. While some HPV types lead to the development of genital warts, others are associated with more serious health risks, including various cancers such as cervical, vulvar, vaginal, anal, and penile cancers. The nucleic acid tests, particularly those indicated by this code, are crucial for identifying specific HPV types that are known to cause cancer, including HPV types 6, 11, 16, and 18. The testing process involves obtaining scrapings from the cervix, vagina, male urethra, or anus, depending on the patient’s anatomy and clinical indications. The methodology for this test can vary based on the manufacturer of the test kit, but it typically employs a nucleic acid hybridization method. This involves using a single-stranded chemiluminescent DNA probe that is complementary to the ribosomal RNA of the specific HPV type being tested. To facilitate the release of nucleic acids, a lysate is utilized to rupture the cells. The ribosomal RNA from the HPV then binds with the labeled DNA probe, forming a stable DNA:RNA hybrid. The presence of these hybrids is subsequently detected using a luminometer, which measures the luminescence produced during the reaction. This process is essential for accurately diagnosing HPV infections and determining the appropriate clinical management for affected individuals.